Objective. Effective treatments for rheumatoid arthritis (RA) fatigue are limited. We tested the effect of a pedometerbased intervention on increasing physical activity and decreasing fatigue among individuals with RA. Methods. Participants completed baseline questionnaires; had 1 week of activity monitoring; were randomized to control (education [EDUC]), pedometer and step-monitoring diary (PED), or pedometer and diary plus step targets (PED+) groups, and were followed for 21 weeks. At week 10, questionnaires were administered by phone to all participants. During the final week, all participants again had 1 week of activity monitoring. Primary outcomes were changes in average weekly steps and fatigue (Patient-Reported Outcomes Measurement Information System 7-item questionnaire) from baseline to week 21. Secondary outcomes were self-reported disease activity, physical function, pain interference, and depressive symptoms. Changes in steps were tested using a linear mixed model. Changes in fatigue were tested with repeated-measures models, including baseline, week-10, and week-21 scores. Results. A total of 96 individuals participated. Eight did not complete the 21-week assessments. Both intervention groups significantly increased steps (+1,441 [P = 0.004] for PED and +1,656 [P = 0.001] for PED+), and the EDUC group decreased steps (-747 [P = 0.14]) (group-by-time interaction P = 0.0025). Between-group changes in fatigue were not significantly different (interaction P = 0.21). Mean changes in fatigue scores from baseline to week 21 were -1.6 (withgroup P = 0.26), -3.2 (P = 0.02), and -4.8 (P = 0.0002) for EDUC, PED, and PED+ groups, respectively. Function and self-reported disease activity also improved in the PED and PED+ groups. Conclusion. Provision of pedometers, with and without providing step targets, was successful in increasing activity levels and decreasing fatigue in this sample of individuals with RA.
INTRODUCTION
Fatigue can have a significant impact on quality of life and functioning of people with rheumatoid arthritis (RA) (1, 2) . However, effective treatments for fatigue are limited. RA medications seem to have minimal effects on reducing fatigue (3) (4) (5) . Programs such as cognitive behavioral therapy appear to have a positive impact (6) , but the likelihood of such programs becoming widely available is unknown because of resource requirements.
Our recent study of the sources of fatigue identified physical inactivity as a primary independent predictor of fatigue (7) , a relationship also noted by others (8, 9) . We also found, similar to other published studies, that many individuals with RA have very low levels of physical activity (10, 11) in spite of the demonstrated safety of exercise and published guidelines recommending physical activity for persons with RA (12) . Although studies have examined the impact of exercise interventions on RA outcomes, most have focused on pain or function (13) (14) (15) (16) (17) . Two recent systematic reviews found that physical activity did have beneficial effects on fatigue (18, 19) , but most exercise interventions have been resource intensive, requiring specially trained personnel, highly structured activities, and/or attendance at classes or a specified facility. Each of these components increases cost and barriers to implementation. Recently tested exercise interventions specifically targeting RA fatigue have shown promising effects (20, 21) , but are also unlikely to be widely implemented because of resource requirements.
In contrast to more complex interventions, pedometers are a simple but effective means of increasing physical activity (22) . Studies attempting to increase activity among older adults using pedometers and step-monitoring diaries have found that the devices are easily used and that compliance with pedometer and diary use is good (22, 23) . We developed a simple, pedometer-based intervention to test the effect of increasing physical activity on fatigue among individuals with RA. The trial included a control group and 2 intervention groups, both of which received pedometers and daily step-monitoring diaries, but with different levels of guidance, and addressed the following hypotheses: 1) individuals receiving individualized step-count goals plus a pedometer and a step-monitoring diary will demonstrate greater increases in physical activity than those receiving the pedometer and diary without step targets; both of these groups will demonstrate greater increases in physical activity than the control group, and 2) individuals receiving stepcount goals plus a pedometer and step-monitoring diary will demonstrate greater decreases in fatigue than those receiving the pedometer and diary without step targets; both of these groups will demonstrate greater decreases in fatigue than the control group.
SUBJECTS AND METHODS
Subjects. Participants were recruited from individuals who had participated in previous studies and were from University of California, San Francisco rheumatology clinics. Recruitment occurred between November 2013 and January 2015. Followup visits continued through June 2015. The recruitment goal was 132 participants with 120 completing the study (90% retention), which was calculated to yield ≥80% power to detect a small change in fatigue. Inclusion criteria were physician-diagnosed RA, English-or Spanish-speaking, able to attend 3 in-person research visits, and presence of greater than minimal fatigue. The PROMIS (Patient-Reported Outcome Measurement Information System [https://www.assessmentcenter. net]) Fatigue Short Form 7a, plus 5 additional items from a fatigue item bank were administered, with a potential raw score range of 0-48. A score ≥18 was required for study eligibility.
Exclusion criteria were body mass index (BMI) <20 kg/ m 2 , currently engaging in regular exercise, and nonambulatory or presence of a condition that would limit the ability to walk (e.g., foot deformities, lower-extremity joint surgery upcoming or in past 6 months, myocardial infarction in past 6 months, stroke, congestive heart failure, or severe chronic obstructive pulmonary disease). Use of walking aids was permitted. Once eligibility was confirmed, individuals were scheduled for in-person baseline study visits.
Procedures. At the baseline visit, staff obtained signed consent, administered questionnaires, and measured height and weight. A second in-person visit was scheduled for 1 week later, and all participants were given an activity monitor to wear for the intervening week. Participants were instructed to wear the activity monitor day and night except when showering, bathing, or swimming.
At the second visit, activity monitors were collected and subjects were randomly assigned to an intervention arm. For randomization, sealed envelopes were prepared with group assignments in blocks of random size. Envelopes were numbered and opened sequentially at the time of the second visit. Once the group assignment was revealed, study staff reviewed the specific procedures for that group.
Study groups. Education only (EDUC). The EDUC group received an educational brochure (Be Active Your Way: A Guide for Adults [http://health.gov/paguidelines/pdf/ paguide.pdf]) and a guided discussion of simple ways to increase physical activity in daily life based on the booklet. The brochure was available in English and Spanish.
Pedometer only (PED). The PED group received the educational booklet and discussion, plus a pedometer and a diary to record daily step counts from the pedometer. Participants were shown how to wear the pedometer, and were instructed to wear it from the time they got out of bed in the morning until they went to bed at night, except while showering, bathing, or swimming. The step diary was prepopulated with dates and provided spaces to record each day's steps and notes about other activities, problems with the activity monitor, injuries, or other relevant issues.
Pedometer + step targets (PED+). The PED+ group received the educational booklet and discussion, the pedometer and step diary, and individualized daily step targets.
Step targets were based on the week of activity monitoring between the baseline and randomization visits, and were calculated to increase participants' average daily step counts by 10% for every 2 weeks of the intervention period.
Pedometers. The Jawbone Up pedometer was used for the baseline and final week of monitoring for all groups. This device does not have a visual display, which could have influenced activity levels (24) . The Fitbit Zip was chosen for the intervention groups (PED and PED+ only) because it has a simple visual display, is relatively easy to wear and operate, and does not require connection with a smart phone for use. The online features of the Fitbit Zip were disabled during the study period.
Significance & Innovations
• Although fatigue can have a significant impact on quality of life for individuals with rheumatoid arthritis, effective and feasible treatments are limited.
• We tested the impact of a simple, pedometer-based intervention on physical activity and fatigue. The trial included a control group and 2 intervention groups, both of which received pedometers and daily step-monitoring diaries, but with different levels of guidance.
• Both intervention groups significantly increased activity levels from baseline to final measurement, with little difference in increases between the 2 groups, while the control group's average daily steps declined.
• Both intervention groups significantly decreased fatigue levels, as well as showing improvements in physical function and self-reported disease activity. In contrast, there was no significant change in fatigue, or in the secondary outcomes of physical function or disease activity in the control group.
Followup. The PED and PED+ groups were contacted by phone every 2 weeks to collect recorded step counts. Participants were given the option of reporting by text or e-mail if they preferred. At each 2-week followup, the PED+ group's average daily steps were compared with the target assigned for that period. If individuals met their target, a new step target was calculated to increase steps by 10% from the previous target. If individuals did not meet the target, the existing target remained in place.
All participants were contacted by phone at week 10 for administration of an abbreviated set of questionnaires. At week 19, the Jawbone Up device was sent out for a final week of monitoring during week 20. At week 21, all participants returned for an in-person visit during which study staff collected the Jawbone Up device and final weeks of step diaries (PED and PED+ groups only), administered questionnaires, and collected participant comments about the study. All study procedures and materials were approved by the UCSF Institutional Review Board.
Variables. Primary outcome: weekly average number of daily steps. Steps from the Jawbone Up were chosen a priori to assess baseline and final followup activity levels. Steps were aggregated to determine average daily steps over the 2 1-week periods.
Supplemental analyses used the weekly average number of steps across the entire intervention period for PED and PED+ groups from the Fitbits, recorded in the step diaries. If subjects engaged in physical activities such as swimming or cycling as well as walking, they were instructed to record these activities in their diaries. Nine subjects in the PED group and 6 in the PED+ group reported other activities, including stationary bike riding, swimming, Pilates, and yoga. Using published conversions of time (25) spent in these activities to step counts, daily step counts were adjusted to account for time in activities other than walking.
Primary outcome: fatigue. Fatigue was measured with the PROMIS Fatigue Short Form 7a questionnaire. To score, raw scores were converted to standardized T scores, with a population mean AE SD of 50 AE 10 (26). Higher scores on the PROMIS fatigue scale reflect greater fatigue.
Secondary outcomes. RA disease activity was measured with the Rheumatoid Arthritis Disease Activity Index (RADAI), which includes self-reports of joint pain, swelling, morning stiffness, and global impact (27) . RADAI scores range from 0 to 10, with higher scores reflecting greater activity. Functional impairment was assessed with the Health Assessment Questionnaire (HAQ) (28) . HAQ scores range from 0 to 3, with higher scores reflecting worse function. Pain was measured with the 6-item PROMIS pain interference questionnaire (29) . Higher scores indicate greater impact of pain on daily activities. Depressive symptoms were assessed with the 8-item version of the Patient Health Questionnaire (PHQ-8) (30) . PHQ-8 items are based on Diagnostic and Statistical Manual of Mental Disorders depression criteria. Higher scores reflect greater levels of depressive symptoms.
Other variables. Sociodemographic information (age, duration of RA, race/ethnicity, education, household income, and work status), smoking history, and RA medications were obtained through self-report. BMI was calculated from measured height and weight. Adherence for the PED and PED+ groups was estimated by the proportion of study days for which steps were recorded in the diaries.
Statistical analysis. Group differences in baseline characteristics were assessed with chi-square analyses and analyses of variance. To test changes in steps measured by Jawbone Up for all 3 groups, a linear mixed model was fit. This model included random intercepts and tested the group-by-time interaction, as well as within-group changes.
For the PED and PED+ groups, a linear repeated-measures model was also fit to examine weekly step counts across the entire intervention period. Time was modeled as a continuous variable and the group-by-time interaction was estimated. The model included Jawbone Up steps at baseline as a covariate, random intercepts, random slopes, their covariation, and first-order, auto-regressive residuals.
Changes in fatigue scores were tested with repeatedmeasures models, including baseline, week-10, and week- 21 scores. This model tested the group-by-time interaction across all 3 groups. Time was modeled as a categorical variable, and the models included random intercepts and an auto-regressive residual. The secondary outcomes of PHQ-8, pain interference, HAQ, and RADAI scores were modeled in the same fashion, although HAQ was collected only at baseline and week 21. Models yielded both omnibus group-by-time interactions as well as simple interactions. Using fatigue scores as an example, the omnibus interaction would be based on the 3 groups and a 3-level indicator of time (baseline, week 10, and week 21), and would have 4 df. Such interactions can be difficult to interpret, so to ease interpretation, we also constructed corresponding "simple" interaction terms that each represent a single df. Each simple interaction compared the baseline versus 21-week change across pairs of study groups (e.g., EDUC versus PED). All models were fit to all available data within the linear mixed models framework, which invoked the assumption that data values were missing at random, conditional on the observed modeled data.
We also compared the proportion of participants in each group who were sedentary (<5,000 steps/day [31] ) and achieved healthy levels of activity (≥8,000 steps/day [31] ) at baseline and week 21. A minimally important change (MIC) in daily steps has not been established. However, changes equivalent to 0.5 SD have been shown to approximate an MIC (32) . Evidence also suggests that increases in average daily steps ≥2,800 are associated with significant health benefits (33, 34) . We compared the proportion in each group who met each of these criteria. We also examined the proportion of individuals in each group who achieved an MIC in fatigue. An MIC on the PROMIS fatigue questionnaire has not been identified for individuals with RA. However, in a population of cancer patients, Yost et al identified a potential MIC range of 3-5 points for the PRO-MIS fatigue scale scored on a T score scale (35) . We chose the midpoint of that range, and defined an MIC as 4 points.
RESULTS
Participation. A total of 359 individuals were approached to participate in the study (Figure 1 ). Ninety-one refused prior to determining eligibility. Of the remaining 268, a total of 150 were ineligible. Twenty-two refused participation after determining eligibility, leaving 96 participants. Eight participants (8.3%) dropped out prior to completing the 21-week assessment. Dropouts were significantly older than participants who remained in the study (63.3 years versus 53.6 years; P = 0.03). There were no other significant differences on any of the measured variables between individuals who dropped out and those who completed the study.
Baseline characteristics. Baseline characteristics of the participants are shown in Table 1 . Mean participant age was 54 years, 88% were female, 64% were white, and 22% were Spanish-speaking. The EDUC group was significantly older and had a longer duration of RA. There were no other significant differences among the groups.
Mean daily steps from the baseline week of monitoring were 4,891, with a range of 405 to over 15,000. Fifty-six percent of the sample could be classified as sedentary (i.e., mean daily baseline steps <5,000 [31] ); only 14% averaged daily step counts sufficient to accrue health benefits (≥8,000 steps/day [31] ). Mean AE SD baseline PROMIS Walking Intervention for RA Fatigue fatigue T score was 59.3 AE 6.7, almost 1 SD above the population mean.
Primary outcomes.
Steps: primary (Jawbone, baseline, and week 21 only, all participants). Both intervention groups significantly increased step counts (mean change +1,441 [P = 0.004] for PED and mean change +1,656 [P = 0.001] for PED+) ( Table 2) , whereas the EDUC group decreased steps (mean change À747 [P = 0.14]). Changes within both intervention groups significantly differed from those in the EDUC group (P = 0.0025 for omnibus group-by-time interaction effect; P = 0.003 for simple group-by-time interaction effects: PED versus EDUC; and P = 0.002 for PED+ versus EDUC). Sensitivity analyses were conducted to adjust for differences in age and disease duration among the 3 groups; no substantive differences in results were found.
At baseline, 50%, 64%, and 53% of EDUC, PED, and PED+ groups, respectively, could be classified as sedentary (<5,000 steps/day), and relatively small proportions were achieving healthy activity levels (≥8,000 steps/day) ( Figure 2) . At week 21, 70% of the EDUC group were classified as sedentary, compared to 43% of the PED group and 36% of the PED+ group (P = 0.04). The proportion of the EDUC group achieving a healthy activity level remained around 20%, while the proportions of the PED and PED+ groups achieving health activity doubled (from 9% to 17% for PED and from 15% to 32% for PED+), although group differences in these proportions were not statistically significant. Nine percent of the EDUC group increased steps by 0.5 SD, compared to 33% of the PED group and 48% of the PED+ group (P = 0.008), and 9% of the EDUC group increased by ≥2,800 steps, compared to 30% of the PED group and 29% of the PED+ group (P = 0.14).
Supplemental (Fitbit + diary weekly step counts, PED and PED+ groups only). The average daily steps from the initial Fitbit week of monitoring were similar for the PED and PED+ groups (5,629 for PED; 5,455 for PED+). The general slope for the PED+ group was positive, averaging an increase of about 22 steps per week (P = 0.27), whereas the slope was negative for the PED group, averaging a decline of about 37 steps per week (P = 0.08). Increase 1608 steps (p = .08) Figure 2 . Summary of baseline and followup sedentary and healthy activity levels, changes in activity, and decreases in fatigue. Sedentary activity defined as mean daily steps/day <5,000 (31) . Healthy activity level defined as mean daily steps/day ≥8,000 (31) . An increase of ≥2,800 mean daily steps/day is associated with reduction of health risk (33, 34) . An increase of ≥1,608 mean daily steps/day (0.5 of baseline SD) approximates a minimally important change (MIC) (32) . A decrease in the PROMIS fatigue T score of 4 points approximates an MIC (35). 6 
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The differences in the 2 slopes represented a significant group-by-time interaction effect (P = 0.04) (Figure 3 ).
Fatigue. Mean changes in PROMIS fatigue scores from baseline to week 21 were -1.6, -3.2, and -4.8 for EDUC, PED, and PED+ groups, respectively ( Table 2) . Within-group changes for PED and PED+ groups were statistically significant (P = 0.02 and P = 0.0002, respectively). The repeatedmeasures analysis omnibus group-by-time interaction effect was not statistically significant (P = 0.21). However, simple tests of interaction indicated a statistical trend for the PED+ group to reduce fatigue scores by 3.2 points more than the EDUC group by 21 weeks (P = 0.09). Sensitivity analyses were conducted to adjust for differences in age and disease duration among the 3 groups; no substantive differences in results were found.
Assuming a 4-point MIC, 43%, 56%, and 53% of individuals in the EDUC, PED, and PED+ groups, respectively, achieved an important decline in fatigue (P = 0.57) ( Figure 2 ). The mean change within the PED+ group met the MIC criterion at 21 weeks.
Adherence. Overall, steps were recorded on 88.8% of study days (92.6% for PED and 85.1% for PED+). There were no significant differences in changes in steps or fatigue for individuals with <80% adherence versus ≥80%, or <90% adherence versus ≥90%.
Adverse events. Interviewers asked about "problems" at each contact (every 2 weeks for PED and PED+ groups; at 10 and 21 weeks for the EDUC group). One participant (PED group) reported a calf muscle strain at day 5 and decreased activity for a short period of time, but continued to monitor steps and completed the study. No other adverse effects were reported that were attributed to the intervention.
Secondary outcomes. The EDUC group's RADAI increased significantly from baseline to week 10, with little change between weeks 10 and 21 (Table 3 ). In contrast, RADAI scores for the PED and PED+ groups were relatively stable between baseline and week 10, and then decreased significantly between week 10 and week 21. The omnibus interaction effect was not significant (P = 0.17), but the simple interactions contrasting changes in RADAI between each intervention group versus the EDUC group were significant at 21 weeks (P < 0.05).
HAQ scores remained constant for the EDUC group, but scores within the PED and PED+ groups improved significantly (À0.18 [P = 0.04] for PED and À0.26 [P = 0.002] for PED+). The decrease in HAQ for the PED+ group met the minimal clinically important difference criterion (~0.22) (36) . The omnibus test of the interaction effect was marginally significant (P = 0.09), but the simple interaction comparing PED+ versus EDUC suggested significantly greater improvement in the PED+ group by 21 weeks (P = 0.03).
For both PROMIS pain interference and PHQ-8, there was general improvement for all groups (main effect of time P < 0.0001). Within-group analyses showed statistically significant improvements for the PED and PED+ groups; corresponding improvements within the EDUC group were marginal. There were no significant groupby-time interactions. 
DISCUSSION
Both intervention groups significantly increased Jawbone-recorded activity levels from baseline to final measurement, with little difference in increases between the 2 groups. In contrast, the EDUC group's average daily steps declined. Initially, activity levels were low in the study cohort, with average daily steps~5,000, and half of participants with average daily steps under 4,000. For context, <5,000 steps per day is considered sedentary and associated with health risk (31, 37) . Changes in activity levels for the 2 intervention groups were meaningful: there was a >30% decrease in the proportion of people classified as sedentary, and the number of individuals who met the criterion for a healthy level of activity (≥8,000 steps/day) doubled. Although overall changes in fatigue scores were not significantly different between groups, both intervention groups significantly decreased fatigue levels. In contrast, there was no significant change in fatigue in the EDUC group. The average decrease in fatigue for the PED+ group at 21 weeks met the defined MIC criterion, suggesting a meaningful decrease in fatigue for this group.
The intervention also positively affected secondary outcomes. HAQ scores, self-reported disease activity, and pain interference significantly decreased from baseline to 21 weeks in the pedometer groups. Comparable changes were not seen in the EDUC group. In the past, there was concern 8 Katz et al that physical activity or exercise might exacerbate RA symptoms. Our findings are similar to previous reports that exercise did not lead to worsened RA. This is particularly important in light of the unsupervised and unguided nature of our intervention. Depressive symptoms significantly decreased in the intervention groups. Exercise has been established as an effective treatment for depression in general population studies. Depression rates are elevated in RA, so confirming that physical activity has a positive effect on depression in RA could open a potentially important new intervention strategy.
The baseline and final week of monitoring with the Jawbone Up device, defined as the primary outcome measure, indicated an increase in activity levels in both intervention groups, while the weekly monitoring with the Fitbit Zip suggested a decreasing trend during the intervention period for the PED group (Figure 3 ). It appeared that the PED group started the intervention with a large increase in steps from baseline to the first week (from an average of 4,223 at baseline to 5,629 at week 1, an increase of 1,406 steps), while the PED+ group's increase from baseline to week 1 was smaller (from 5,019 to 5,455, an increase of 436 steps). The more gradual increase of the PED+ group, guided by targets, may have led to greater adherence over time. It is also possible that the larger initial increase in the PED group led to higher levels of fatigue or symptoms that discouraged continued increases in activity. We cannot directly compare the output of the baseline and weekly monitoring because different devices were used, so this phenomenon deserves further attention in future studies.
Some studies have shown that providing incremental targets is more effective in increasing step counts than providing a pedometer alone (38, 39) . We did not find clear evidence that this was the case. It is possible that for certain individuals, targets may be more effective, and, as noted above, guidance for more incremental increases may increase adherence over time. More research is needed both to determine the most effective means of delivering the intervention, and to identify individuals who may need the additional support or motivation of targets.
This study has limitations. First, the sample size limited our ability to measure differences among groups. However, the results were encouraging with significant within-group changes in both activity and fatigue for the intervention groups, and provide support for a larger trial. It was not possible to determine the intensity of activity (e.g., speed of walking) from the devices used. Some studies have shown that higher intensity activities have greater benefits, particularly for depression. These devices also did not provide actual wear time as some activity monitors do, so our measure of adherence can only be considered an estimate. However, the commercially available intervention devices were simple to use and are readily available, and our study demonstrates the value of monitoring alone. We experienced technical difficulties with monitoring devices, such as device failure and subjects forgetting to wear the devices. These difficulties are likely to happen in any similar intervention, but they also create missing data that can affect both study power and analyses. There is also error in the measurement of activity by these devices (40) . It is likely that regular contact with study personnel affected adherence, even though staff attempted to maintain neutral reactions when they collected data at the 2-week phone check-ins. Future studies might attempt to quantify the effect of this type of social interaction.
In summary, provision of pedometers, with and without providing guidance in the form of step targets, was successful in increasing activity levels in these individuals with RA. While decreases in fatigue were not statistically different across groups, fatigue did significantly decrease in both pedometer groups, with over 50% reporting clinically important decreases in fatigue. Significant improvements in other outcomes were also noted for the 2 pedometer groups. Our results provide evidence that pedometers are effective at increasing physical activity among people with RA, and provide support for the hypothesis that increasing physical activity by walking has important effects on fatigue and other RA symptoms.
